BioCentury
ARTICLE | Finance

Cashing in on Conformations

Biodesy expects A round enough to get protein structure platform to market

October 21, 2013 7:00 AM UTC

Biodesy Inc. has yet to commercialize its system for protein structure analysis, but a trio of investors are betting the platform's low cost and simplicity will eventually allow for scalability and customizability.

Last week, Biodesy raised $15 million in a series A round led by 5AM Ventures. Pfizer Venture Investments and Roche Venture Fund also participated. All are new investors...